Literature DB >> 31086264

Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis.

Frauke Zipp1, Jiwon Oh2, Yara Dadalti Fragoso3, Emmanuelle Waubant4.   

Abstract

The latest revision of the McDonald criteria for the diagnosis of multiple sclerosis (MS) was published online in 2017. New features of the criteria, which were designed to facilitate earlier diagnosis of MS, include the recognition of oligoclonal bands in the cerebrospinal fluid as a possible marker of dissemination of MS pathology in time, the introduction of symptomatic lesions as a parameter to demonstrate spatial or temporal pathology dissemination, and the use of cortical lesions to demonstrate dissemination in space. In this Viewpoint, a panel of world-renowned MS specialists share their personal experiences of the new criteria to date.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31086264     DOI: 10.1038/s41582-019-0194-0

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  6 in total

Review 1.  [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].

Authors:  Heinz Wiendl; Ralf Gold; Thomas Berger; Tobias Derfuss; Ralf Linker; Mathias Mäurer; Martin Stangel; Orhan Aktas; Karl Baum; Martin Berghoff; Stefan Bittner; Andrew Chan; Adam Czaplinski; Florian Deisenhammer; Franziska Di Pauli; Renaud Du Pasquier; Christian Enzinger; Elisabeth Fertl; Achim Gass; Klaus Gehring; Claudio Gobbi; Norbert Goebels; Michael Guger; Aiden Haghikia; Hans-Peter Hartung; Fedor Heidenreich; Olaf Hoffmann; Zoë R Hunter; Boris Kallmann; Christoph Kleinschnitz; Luisa Klotz; Verena Leussink; Fritz Leutmezer; Volker Limmroth; Jan D Lünemann; Andreas Lutterotti; Sven G Meuth; Uta Meyding-Lamadé; Michael Platten; Peter Rieckmann; Stephan Schmidt; Hayrettin Tumani; Martin S Weber; Frank Weber; Uwe K Zettl; Tjalf Ziemssen; Frauke Zipp
Journal:  Nervenarzt       Date:  2021-07-23       Impact factor: 1.214

2.  Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome.

Authors:  Yang Zheng; Chun-Hong Shen; Sa Wang; Fan Yang; Meng-Ting Cai; Wei Fang; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Ther Adv Neurol Disord       Date:  2020-01-20       Impact factor: 6.570

3.  Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.

Authors:  Zahra Salehi; Amir Almasi-Hashiani; Mohammad Ali Sahraian; Fereshteh Ashtari; Seyed Mohammad Baghbanian; Nazanin Razazian; Abdorreza Naser Moghadasi; Asghar Bayati; Amir Reza Azimi; Nahid Beladimoghadam; Mohammad Hossein Harirchian; Maryam Poursadeghfard; Samira Navardi; Reza Shirkoohi; Hora Heidari; Mehran Ghaffari; Sharareh Eskandarieh
Journal:  BMC Neurol       Date:  2022-03-05       Impact factor: 2.474

4.  RNA Sequencing of CD4+ T Cells in Relapsing-Remitting Multiple Sclerosis Patients at Relapse: Deciphering the Involvement of Novel genes and Pathways.

Authors:  Saeed Talebi; Samaneh Maleknia; Fahimeh Palizban; Zahra Salehi; Abdorreza Naser Moghadasi; Kaveh Kavousi; Mohammad Ali Sahraian; Maryam Izad
Journal:  J Mol Neurosci       Date:  2021-07-21       Impact factor: 3.444

Review 5.  The potential of serum neurofilament as biomarker for multiple sclerosis.

Authors:  Stefan Bittner; Jiwon Oh; Eva Kubala Havrdová; Mar Tintoré; Frauke Zipp
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

6.  Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity.

Authors:  Razieh Amini; Sajad Karampoor; Hamid Zahednasab; Hossein Keyvani; Masoud Gheiasian; Farid Azizi Jalilian
Journal:  Braz J Infect Dis       Date:  2020-03-31       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.